Asthma Trial, Recruiting NCT07516184 Sponsor: AstraZeneca Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT07516184
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 75 years old at the time of joining the trial
  • People who have experienced asthma-like symptoms — such as wheezing, shortness of breath, chest tightness, or coughing — for at least 2 months before joining, whether or not they have been formally diagnosed with asthma

Who may not be able to join:

  • People who have had a respiratory infection in the 3 months before joining, including pneumonia, bronchitis, flu, or COVID-19
  • People who currently smoke, stopped smoking less than 6 months ago, or stopped more than 6 months ago but smoked more than 10 packs per year during their lifetime
  • People with a history of other long-term lung conditions besides asthma, such as tuberculosis, significant bronchiectasis, interstitial lung disease, or lung cancer
  • People with serious ongoing health conditions affecting the heart, gut, liver, kidneys, nerves, muscles, hormones, blood, or mental health that the trial doctor considers unstable or likely to interfere with the study
  • People who are pregnant, breastfeeding, have a positive pregnancy test, or are planning to become pregnant within 3 months
  • People who have used inhaled corticosteroid-based medications (including certain combination inhalers) within the 3 months before joining (confirm with trial site for specific medication names)
  • People the trial doctor believes are unlikely to follow the study procedures or requirements
  • People who are currently taking part in another interventional clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: KeWu Huang, Doctor, Beijing Chao-Yang Hospital, 8 Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, China

Phone: 1-877-240-9479

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
10 June 2026
Est. completion
11 June 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

To explore the diagnostic value of portable oscillometry in suspected asthma patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov